News

Deadline Approaches for Ultra Clean Holdings Class Action Suit

Deadline Approaches for Ultra Clean Holdings Class Action Suit

Ultra Clean Holdings, Inc. Class Action Lawsuit Overview

Investors and stakeholders of Ultra Clean Holdings, Inc., often referred to as Ultra Clean, are encouraged to take action as a class action lawsuit emerges. The lawsuit, which revolves around alleged securities fraud, is spearheaded by Levi & Korsinsky, LLP, a firm that has a well-established reputation for representing shareholders.

Understanding the Class Action

The class action seeks to recover losses for investors adversely affected by misleading statements regarding Ultra Clean's business performance. The relevant time frame for the alleged fraudulent activities spans from May 6, 2024, to February 24, 2025. All affected investors are strongly encouraged to consider participating in the lawsuit to seek redress.

Details of the Allegations

The complaint highlights that Ultra Clean provided materially false information to its investors concerning the demand for its products in the Chinese market. This included optimistic previsions about the revenue growth and an increase in product demand. While the company touted strong performance, it was reportedly concealing critical issues, including customer ramp challenges and inventory discrepancies that contributed to a decline in demand.

Impact on Stock Price

On February 24, 2025, Ultra Clean publicly announced its fourth-quarter results, revealing that it was experiencing demand softness specifically in the Chinese market. This announcement led to a precipitous drop in Ultra Clean's stock price, from $36.06 per share to $25.90 per share within a day, reflecting over a 28% decline. Such fluctuations underscore the seriousness of the allegations and the need for investor awareness.

Next Steps for Investors

Investors who suffered losses during the stipulated period must act quickly. The deadline to request appointment as lead plaintiff in this case is May 23, 2025. Importantly, if appointed as a lead plaintiff, investors may still share in financial recovery without the obligation to undertake further responsibilities.

No Cost to Participate

For affected investors, there is no financial risk involved in enrolling as a class member. Participation offers the potential for compensation based on the outcomes from the lawsuit, with no out-of-pocket expenses or hidden fees required.

Why Choose Levi & Korsinsky?

Levi & Korsinsky boasts an impressive track record of securing favorable outcomes in high-stakes litigation for investors. Their commitment over the past two decades has yielded hundreds of millions of dollars for their clients. The firm has more than 70 dedicated professionals ready to support investors through complex securities litigation. For seven consecutive years, they have been recognized as one of the leading securities litigation firms.

Contact Information

For those interested in pursuing the class action or seeking more information, Joseph E. Levi, Esq. and Ed Korsinsky, Esq. at Levi & Korsinsky, LLP are available for consultation. You can reach them at:

33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Email: [email protected]
Website: www.zlk.com

Frequently Asked Questions

What is the primary focus of the class action lawsuit?

The lawsuit targets alleged securities fraud committed by Ultra Clean Holdings, Inc. that impacted shareholder investments during a specific period.

Who can participate in the class action?

Any investor who experienced losses while holding Ultra Clean shares between May 6, 2024, and February 24, 2025, is eligible to join the lawsuit.

What deadlines should investors be aware of?

Investors must act before May 23, 2025, to request lead plaintiff status in the suit.

Are there any costs associated with joining the lawsuit?

No, there are no costs or obligations for investors to participate as class members.

Why is Levi & Korsinsky a reliable choice for legal representation?

Levi & Korsinsky has a robust history of winning significant settlements for investors and extensive experience in securities litigation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 6

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Crunch Fitness Expands with New State-of-the-Art Facility

Updated Category News Views 448

Exciting Launch of Crunch Fitness in New Location Crunch Fitness is set to enhance the fitness experience for all in its newest location, a state-of-the-art facility designed to invigorate the community. Positioned at 4701 Colleyville Blvd, this modern gym promises to redefine conventional workout spaces. With elegant lighting and a sleek design,Crunch Colleyville aims to...

Continue Reading
Meketa Capital Unveils New Infrastructure Fund for Advisors

Updated Category News Views 57

Exciting Launch of the Meketa Infrastructure Fund Meketa Capital has made an impactful move by launching the Meketa Infrastructure Fund, which is aimed at registered investment advisors (RIAs). This fund is now accessible through Fidelity’s Institutional Wealth Services and National Financial marketplaces, expanding options for advisors and their clients. Access to a...

Continue Reading
BrightPath Child Care Expands with New School Opening

Updated Category News Views 521

BrightPath Early Learning Opens New Facility in Sugar Grove BrightPath Early Learning and Child Care, a leading provider of early childhood education, proudly announces the opening of its new location in Sugar Grove. This marks a significant milestone as it expands its reach in the Chicago area, adding another option for families seeking high-quality child care services....

Continue Reading
Baltic Horizon Fund Announces SDR Program Termination Plans

Updated Category News Views 133

Baltic Horizon Fund's Termination of SDR Program On February 13, 2025, Baltic Horizon Fund (the Fund) announced the decision to terminate its Swedish Depositary Receipts (SDR) program and subsequently delist from Nasdaq Stockholm. This significant change comes as the Fund aims to streamline its operations and enhance efficiency in the market. Notice of Termination for SDR...

Continue Reading
Cereno Scientific Advances Clinical Trials for PAH Treatment

Updated Category News Views 184

Cereno Scientific Submits Protocol for Phase IIb Trial of CS1 Cereno Scientific, a pioneering biotech, has taken a significant step forward by submitting its Phase IIb trial protocol for CS1 to the U.S. Food and Drug Administration (FDA). This submission marks an important milestone in the company's efforts to enhance healthcare for patients living with pulmonary arterial...

Continue Reading